Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03290027 · ClinicalTrials.gov registry record · Phase 3
A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris
A Phase 3 study, sponsored by Dr. Reddy's Laboratories Limited.
- Completed
- Registry status
- Phase 3
- Development phase
- 550
- Enrollment target
NCT03290027 is a Phase 3 study that has completed, run by Dr. Reddy's Laboratories Limited. The registered enrollment target is 550 participants.
The verdict
NCT03290027, a Phase 3 study, has completed, sponsored by Dr. Reddy's Laboratories Limited.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 550 participants
- Enrollment target
Study Summary
Enrollment of subjects with mild to moderate facial acne. Efficacy was assessed by using an Investigator's Global Assessment scale (IGA 5 point scale) and by counting the number of inflammatory and non-inflammatory lesions on the face at Baseline and Weeks 4, 8, and 12. Safety assessments included the investigator's assessment of local cutaneous tolerance of the treated skin (dryness, non-lesional erythema, peeling, stinging, burning, and itching, vital signs, and adverse events (AEs).
Interventions
- OTHER Placebo Comparator
- DRUG DFD-03
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2017-07-31 |
| Est. Completion | 2018-04-19 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03290027
The ClinicalTrials.gov registry entry for NCT03290027 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dr. Reddy's Laboratories Limited, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Comparator is the first listed.
NCT03290027 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03290027 about?
NCT03290027 is a clinical study titled "A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris". Enrollment of subjects with mild to moderate facial acne. Efficacy was assessed by using an Investigator's Global Assessment scale (IGA 5 point scale) and by counting the number of inflammatory and non-inflammatory lesions on the face at Baseline and Weeks 4, 8, and 12. Safety assessments included ...
What is the current status of trial NCT03290027?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 550 participants. The study started on 2017-07-31. Estimated completion is 2018-04-19.
What interventions are being tested in trial NCT03290027?
The interventions under investigation include: Placebo Comparator (OTHER), DFD-03 (DRUG).
Who is sponsoring clinical trial NCT03290027?
This trial is sponsored by Dr. Reddy's Laboratories Limited, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.